X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (157) 157
male (109) 109
female (106) 106
infectious diseases (104) 104
index medicus (95) 95
adult (84) 84
hiv infections - virology (77) 77
hiv-1 - genetics (72) 72
hiv (70) 70
hiv infections - drug therapy (68) 68
immunology (67) 67
virology (67) 67
middle aged (61) 61
human immunodeficiency virus--hiv (44) 44
drug resistance (42) 42
hiv infection (42) 42
microbiology (42) 42
antiretroviral therapy (41) 41
cohort studies (41) 41
infection (41) 41
hiv-1 - drug effects (40) 40
hiv infections - transmission (38) 38
viral load (37) 37
antiretroviral drugs (35) 35
610 medicine & health (34) 34
genotype (34) 34
switzerland (34) 34
hiv infections - epidemiology (33) 33
anti-hiv agents - therapeutic use (32) 32
mutation (32) 32
transmission (32) 32
research (31) 31
switzerland - epidemiology (30) 30
drug therapy (29) 29
hiv-1 (28) 28
clinic for infectious diseases (27) 27
immunodeficiency-virus type-1 (27) 27
prevalence (27) 27
hiv-1 - isolation & purification (26) 26
aids (25) 25
drug-resistance (25) 25
phylogeny (25) 25
rna (25) 25
virus diseases (25) 25
antiretroviral therapy, highly active (23) 23
hiv infections - immunology (23) 23
rna, viral - blood (23) 23
cd4 lymphocyte count (22) 22
infections (22) 22
institute of medical virology (22) 22
risk factors (22) 22
anti-hiv agents - pharmacology (21) 21
care and treatment (21) 21
drug resistance, viral (21) 21
health aspects (21) 21
mutations (21) 21
aged (20) 20
disease transmission (20) 20
epidemiology (20) 20
treatment outcome (20) 20
hiv 1 (19) 19
hiv-1 - classification (19) 19
reverse-transcriptase (19) 19
therapy (19) 19
analysis (18) 18
hiv infections - genetics (18) 18
human immunodeficiency virus (18) 18
human-immunodeficiency-virus (18) 18
patients (18) 18
prospective studies (18) 18
viruses (18) 18
viremia (17) 17
hiv infections - diagnosis (16) 16
hiv-1 - immunology (16) 16
medicine (16) 16
plasma (16) 16
research article (16) 16
resistance (16) 16
reverse transcriptase inhibitors - therapeutic use (16) 16
570 life sciences; biology (15) 15
drug resistance, viral - genetics (15) 15
genetic aspects (15) 15
algorithms (14) 14
antiviral agents (14) 14
hiv reverse transcriptase - genetics (14) 14
hiv-1 - physiology (14) 14
medicine, general & internal (14) 14
pharmacology & pharmacy (14) 14
cluster analysis (13) 13
hiv/aids (13) 13
molecular epidemiology (13) 13
aids/hiv (12) 12
cohort (12) 12
logistic models (12) 12
multidisciplinary sciences (12) 12
sequence analysis, dna (12) 12
treatment failure (12) 12
type-1 (12) 12
abridged index medicus (11) 11
genetic mutation (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Infectious Diseases, ISSN 1473-3099, 03/2018, Volume 18, Issue 3, pp. 239 - 240
Antiretroviral therapy (ART) coverage among people living with HIV reached 53% worldwide in 2016, representing 21 million people on treatment.1 As the number... 
INFECTIOUS DISEASES | COHORT | HIV Infections | Regression Analysis | Drug Resistance, Viral - drug effects | Anti-Retroviral Agents | HIV-1 - drug effects | Humans | Low income groups | Antiretroviral drugs | Human immunodeficiency virus--HIV | Mutation | Pretreatment | Drug resistance | Drug therapy | Epidemiology | Public health
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 10, pp. 1156 - 1166
Summary Background Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a... 
Infectious Disease | INFECTIOUS DISEASES | MARBURG VIRUS | ACTIVATION | DUCK RUBELLA VACCINE | IMMUNE-RESPONSES | PROTECTS NONHUMAN-PRIMATES | VESICULAR STOMATITIS | GLYCOPROTEINS | INFECTION | FEVER | AGE | Hemorrhagic Fever, Ebola - prevention & control | Vasculitis - epidemiology | Arthritis - epidemiology | Humans | Middle Aged | Vasculitis - pathology | Antigens, Viral - genetics | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Ebolavirus - genetics | Antibodies, Viral - blood | Dermatitis - epidemiology | Drug Carriers | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Arthritis - chemically induced | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vesiculovirus - genetics | Adult | Ebola Vaccines - immunology | Female | Vasculitis - chemically induced | Placebos - administration & dosage | Double-Blind Method | Arthritis - pathology | Ebola Vaccines - administration & dosage | Ebola Vaccines - adverse effects | Switzerland | Drug-Related Side Effects and Adverse Reactions - epidemiology | Dermatitis - pathology | Adolescent | Aged | Vaccines, Synthetic - administration & dosage | Ebola virus | Hospitals | Clinical trials | Product development | Cross infection | Vaccines | Nosocomial infections | Health aspects | Epidemics | Disease | Arthritis | Dermatitis | Ankle | Wrist | Consortia | Pain | Adenoviruses | Fingers & toes | Skin | Public health
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, p. e18164
Background: Intervention with antiretroviral treatment (ART) and control of viral replication at the time of HIV-1 seroconversion may curtail cumulative... 
IMMUNE CONTROL | STRUCTURED TREATMENT INTERRUPTIONS | PERFORIN EXPRESSION | MEDIATED CYTOTOXICITY | FUNCTIONAL SIGNATURES | ACUTE HIV-1 INFECTION | BIOLOGY | HLA-B | IMMUNODEFICIENCY-VIRUS-REPLICATION | VIRAL CONTROL | HIV-1-INFECTED SUBJECTS | Anti-HIV Agents - pharmacology | Species Specificity | Humans | Middle Aged | Male | HIV Long-Term Survivors | T-Lymphocytes - virology | Epitopes - immunology | HIV Infections - immunology | HIV-1 - physiology | T-Lymphocytes - metabolism | Time Factors | T-Lymphocytes - drug effects | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - blood | Virus Replication - drug effects | HIV-1 - drug effects | HIV Infections - genetics | Genotype | Histocompatibility Antigens Class I - genetics | Gene Expression Regulation - drug effects | CD8 Antigens - metabolism | HIV-1 - immunology | HIV Infections - drug therapy | T-Lymphocytes - immunology | Aged | Perforin - metabolism | gag Gene Products, Human Immunodeficiency Virus - immunology | CD4 Antigens - metabolism | Cohort Studies | Highly active antiretroviral therapy | Antiviral agents | RNA | Comparative analysis | T cells | HIV (Viruses) | Flow cytometry | Antiretroviral drugs | CD8 antigen | Cytotoxicity | Lymphocytes T | T cell receptors | Tumor necrosis factor-α | Ribonucleic acid--RNA | Seroconversion | Antiretroviral therapy | CD4 antigen | Cytometry | Immunology | Interleukin 2 | Antiretroviral agents | Human immunodeficiency virus--HIV | γ-Interferon | Peripheral blood | Replication | Interferon | Perforin | Viral infections | Deoxyribonucleic acid--DNA | Deoxyribonucleic acid | Ribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2016, Volume 22, Issue 11, pp. 1260 - 1267
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1647 - 1660
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/1995, Volume 333, Issue 7, pp. 408 - 413
Journal Article
by Kuster, Sabine and Stampf, Susanne and Gerber, Bernhard and Baettig, Veronika and Weisser, Maja and Gerull, Sabine and Medinger, Michael and Passweg, Jakob and Schanz, Urs and Garzoni, Christian and Berger, Christoph and Chalandon, Yves and Mueller, Nicolas J and Delden, Christian and Neofytos, Dionysios and Khanna, Nina and Achermann, Rita and Amico, Patrizia and Aubert, John‐David and Banz, Vanessa and Beldi, Guido and Benden, Christian and Binet, Isabelle and Bochud, Pierre‐Yves and Bucher, Heiner and Carell, Thierry and Catana, Emmanuelle and Geest, Sabina and Rougemont, Olivier and Dickenmann, Michael and Duchosal, Michel and Elkrief, Laure and Fehr, Thomas and Ferrari‐Lacraz, Sylvie and Soccal, Gasche and Gaudet, Christophe and Giostra, Emiliano and Golshayan, Déla and Hadaya, Karine and Halter, Jörg and Heim, Dominik and Hess, Christoph and Hillinger, Sven and Hirsch, H and Hofbauer, Günther and Huynh‐Do, Uyen and Immer, Franz and Klaghofer, Richard and Koller, Michael and Laesser, Bettina and Lehmann, Roger and Lovis, Christian and Majno, Pietro and Manuel, Oriol and Marti, Hans‐Peter and Martin, Yves and Meylan, Pascal and Mohacsi, Paul and Morel, Philippe and Mueller, Ulrike and Mueller‐McKenna, Helen and Müller, Antonia and Müller, Thomas and Müllhaupt, Beat and Nadal, David and Pascual, Manuel and Rick, Juliane and Roosnek, Eddy and Rosselet, Anne and Rothlin, Silvia and Ruschitzka, Frank and Schaub, Stefan and Schnyder, Aurelia and Seiler, Christian and Steiger, Jürg and Stirnimann, Guido and Toso, Christian and Venetz, Jean‐Pierre and Villard, Jean and Wick, Madeleine and Wilhelm, Markus and Yerly, Patrick and Swiss Transplant Cohort Study
Transplant Infectious Disease, ISSN 1398-2273, 12/2018, Volume 20, Issue 6, pp. e12981 - n/a
Journal Article